Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Barbieri

Showing results (301-310 of 305) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 305 results.
Nature Genetics|May 22, 2012
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerChristopher E Barbieri, Sylvan C Baca, Michael S Lawrence, et al.
ESMO Open|January 8, 2025
Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patientsE A Martino, S Palmieri, M Galli, et al.
JCO Precision Oncology|October 9, 2019
Integrative Molecular Analysis of Patients With Advanced and Metastatic CancerVerena Sailer, Kenneth Wa Eng, Tuo Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2025
Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancerT Virtanen, E M Kwan, K Parekh, et al.
Neuro-Oncology Practice|June 3, 2015
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?Alba A Brandes, Enrico Franceschi, Mario Ermani, et al.
Pageof 31

Showing results (301-310 of 305) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 305 results.
Nature Genetics|May 22, 2012
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerChristopher E Barbieri, Sylvan C Baca, Michael S Lawrence, et al.
ESMO Open|January 8, 2025
Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patientsE A Martino, S Palmieri, M Galli, et al.
JCO Precision Oncology|October 9, 2019
Integrative Molecular Analysis of Patients With Advanced and Metastatic CancerVerena Sailer, Kenneth Wa Eng, Tuo Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2025
Repertoire and clinical hierarchy of AR locus alterations in castration-resistant prostate cancerT Virtanen, E M Kwan, K Parekh, et al.
Neuro-Oncology Practice|June 3, 2015
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?Alba A Brandes, Enrico Franceschi, Mario Ermani, et al.
Pageof 31